Relief Therapeutics Holding SA (XSWX:RLF) Share Price

Company Profile

Business description
Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products, and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Its pipeline includes various drug candidates in their different stages of development, such as RLF-TD011 and RLF-100, among others. It also has commercial legacy products like Cambia, Setofilm, Voltadol, and Voltfast, among others. Geographically, the company generates a majority of its revenue from Europe (excluding Switzerland) and the rest from North America, Switzerland, and the rest of the world.
Contact
Avenue de Secheron 15
Geneva1202
CHE
T: +41 225451116
https://www.relieftherapeutics.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
31

Recommended

Does recent share price weakness spell opportunity in these three high-quality companies? Our analysts think so.

Joseph Taylor | 11 September 2025

The media group has excelled in controlling what it can control. Now the focus shifts to capital deployment.

Brian Han | 11 September 2025

Shares jumped in response to the latest results.

Luke Yang, CFA | 11 September 2025

Index	Last price	Change	% Change
All Ordinaries	9,128.70	18.10	0.20%
CAC 40	7,825.24	1.72	0.02%
DAX 40	23,698.15	5.50	-0.02%
Dow JONES (US)	45,834.22	273.78	-0.59%
FTSE 100	9,283.29	14.29	-0.15%
HKSE	26,388.16	301.84	1.16%
NASDAQ	22,141.10	98.03	0.44%
Nikkei 225	44,768.12	395.62	0.89%
NZX 50 Index	13,227.90	1.25	-0.01%
S&P 500	6,584.29	3.18	-0.05%
S&P/ASX 200	8,864.90	22.00	0.25%
SSE Composite Index	3,870.60	4.71	-0.12%